drugset / Trial / NCT01136915

Kidney Damage In Patients With Severe Fall In eGFR

NCT01136915 ↗

Phase 4 Terminated 15 enrolled Bracco Diagnostics, Inc
RandomizedParallel-groupTriple-blindDiagnostic

Summary

This is a pilot study using a randomized, double blinded, comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have and estimated glomerular filtration \[eGFR\] \< 30 mL/min/1.73 m2. Statistical summaries will be presented to analyse the various laboratory tests for the two groups.

Timeline

Start
2010-11
Primary completion
2012-11
Completion
2012-11

Outcome

Outcome not reported

Stopped (Enrollment): “slow enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodixanol Diagnostic / imaging agent — —
Comparator Iopamidol Diagnostic / imaging agent — —

Indications